BVS BREAKING NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Bioventus Inc. Investors to Inquire About Securities Class Action Investigation - BVSPRNewsWire • 11/30/22
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Bioventus Inc. (BVS) on Behalf of InvestorsBusiness Wire • 11/29/22
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Bioventus Inc. (BVS) on Behalf of InvestorsBusiness Wire • 11/29/22
The Law Offices of Frank R. Cruz Announces Investigation of Bioventus Inc. (BVS) on Behalf of InvestorsBusiness Wire • 11/29/22
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Bioventus Inc. Investors to Inquire About Securities Class Action Investigation – BVSBusiness Wire • 11/28/22
Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial GuidanceGlobeNewsWire • 11/21/22
Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022GlobeNewsWire • 11/16/22
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Bioventus Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 11/14/22
INVESTIGATION NOTICE: The Schall Law Firm Announces It Is Investigating Claims Against Bioventus Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 11/11/22
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Bioventus Inc. and Encourages Investors with Losses to Contact the FirmBusiness Wire • 11/10/22
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Bioventus Inc. and Encourages Investors with Losses to Contact the FirmBusiness Wire • 11/09/22
Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial GuidanceGlobeNewsWire • 11/08/22
Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022GlobeNewsWire • 10/31/22
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in ChicagoGlobeNewsWire • 10/12/22
Bioventus Inc. (BVS) CEO Ken Reali on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial GuidanceGlobeNewsWire • 08/11/22
Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022GlobeNewsWire • 07/26/22